Thorax in focus: chronic obstructive pulmonary disease
- 1NIHR Nottingham Respiratory Biomedical Research Unit, University of Nottingham, Nottingham, UK
- 2Institute for Lung Health, Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK
- Correspondence to Dr Michael C Steiner, Institute for Lung Health, Department of Respiratory Medicine, Glenfield Hospital, Leicester LE3 9QP, UK; michael.steiner{at}uhl-tr.nhs.uk
-
Contributors All authors contributed to the writing of the article.
- Received 14 October 2011
- Accepted 18 November 2011
- Published Online First 8 December 2011
Abstract
Keeping up to date with scientific developments in any field of medicine is challenging, and chronic obstructive pulmonary disease (COPD) is no exception. Thorax has played an important part in the communication of key developments to its readership. In this article we review original research published in the journal over the last 2-3 years. We consider scientific and clinical developments in the epidemiology, mechanisms and treatment of COPD, placing these articles in the context of other relevant literature in COPD.
- Asthma mechanisms
- COPD mechanisms
- COPD epidemiology
- COPD pathology
- cough/mechanisms/pharmacology
- eosinophil biology
- exhaled airway markers
- perception of asthma/breathlessness
- immunodeficiency
- pulmonary vasculitis
- drug-induced lung disease
- interstitial fibrosis
- COPD exacerbations
- cystic fibrosis
- cytokine biology
- emphysema
- pulmonary rehabilitation
- exercise
Footnotes
-
David B Hodgson and Gauri Saini are joint first authors.
-
Competing interests None.
-
Provenance and peer review Commissioned; externally peer reviewed.
